Anti‐Amyloid Aggregation and Anti‐Hyperglycemic Activities of Novel Ruthenium Uracil Schiff Base Compounds
ChemMedChem · 02.12.2024 · 19 (23)
DOI: 10.1002/cmdc.202400477 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 09.11.2024. Verfasst von Daniel M Makanyane und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa. Hauptthemen laut MEDLINE: Schiff Bases, Ruthenium, Uracil, Hypoglycemic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: National Research Foundation of South Africa, University of KwaZulu-Natal, Inyuvesi Yakwazulu-Natali.
Abstract (Originalsprache)
The formation and characterization of new diamagnetic ruthenium uracil mono‐imine compounds: [( η 6 ‐ p ‐cymene)Ru II (L)Cl][BF 4 ] (L=H 2 urpda=5‐((pyridin‐2‐yl)methyleneamino)‐6‐aminouracil) for 1 , urdpy=6‐amino‐1,3‐dimethyl‐5‐((pyridin‐2‐ylmethylene)amino)uracil) for 2 or urqda=5‐((quinolin‐2‐yl)methyleneamino)‐6‐aminouracil) for 3 ); cis ‐[Ru(bipy) 2 (urpy)](BF 4 ) 2 ( 4 ) (urpy=5‐((pyridin‐2‐yl)methyleneamino)uracil) and cis‐ [Ru(bipy) 2 (dapd)] ( 5 ) (H 2 dadp=5,6‐diaminouracil) are described. A ruthenium(IV) uracil Schiff base compound, trans ‐[Ru(urpda)(PPh 3 )Cl 2 ] ( 6 ) was also formed. Various physicochemical techniques were utilized to characterize the novel ruthenium compounds. Similarly, the stabilities of 1 – 3 and 6 monitored in chloro‐containing and the non‐coordinating solvent, dichloromethane show that they are kinetically inert, whereas, in a high nucleophilic environment, the chloride co‐ligands of these ruthenium complexes were rapidly substituted by DMSO. In contrast, the substitution of the labile co‐ligands for these ruthenium complexes by DMSO molecules in a high chloride content was suppressed. Solution chemical reactivities of the different ruthenium complexes were rationalized by density functional theory computations. Furthermore, the binding affinities and strengths between BSA and the respective ruthenium complexes were monitored using fluorescence spectroscopy. In addition, the in vitro anti‐diabetic activities of the novel metal complexes were assessed in selected skeletal muscle and liver cell lines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
- School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Irvin N Booysen
Förderung
- National Research Foundation of South Africa
- University of KwaZulu-Natal
- Inyuvesi Yakwazulu-Natali
Zitieren
APA
Makanyane, D. M., Mabuza, L. P., Ngubane, P., Khathi, A., Mambanda, A., & Booysen, I. N. (2024). Anti‐Amyloid Aggregation and Anti‐Hyperglycemic Activities of Novel Ruthenium Uracil Schiff Base Compounds. ChemMedChem, 19(23). https://doi.org/10.1002/cmdc.202400477
Vancouver
Makanyane DM, Mabuza LP, Ngubane P, Khathi A, Mambanda A, Booysen IN. Anti‐Amyloid Aggregation and Anti‐Hyperglycemic Activities of Novel Ruthenium Uracil Schiff Base Compounds. ChemMedChem. 2024;19(23). doi:10.1002/cmdc.202400477
BibTeX
@article{Makanyane2024,
author = {Makanyane, Daniel M and Mabuza, Lindokuhle P and Ngubane, Phikelelani and Khathi, Andile and Mambanda, Allen and Booysen, Irvin N},
title = {Anti‐Amyloid Aggregation and Anti‐Hyperglycemic Activities of Novel Ruthenium Uracil Schiff Base Compounds},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {23},
doi = {10.1002/cmdc.202400477}
}
EUVIMED